Page last updated: 2024-10-23

azathioprine and Odontalgia

azathioprine has been researched along with Odontalgia in 1 studies

Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.

Research Excerpts

ExcerptRelevanceReference
"Granulomatosis with polyangiitis is an uncommon condition characterised by vasculitis and associated granuloma formation with a highly specific autoantibody, namely proteinase 3-anti-neutrophil cytoplasmic antibody (ANCA)."1.43Toothache and hearing loss: early symptoms of granulomatosis with polyangiitis (GPA). ( Brown, P; Conlon, N; Feighery, C, 2016)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brown, P1
Conlon, N1
Feighery, C1

Other Studies

1 other study available for azathioprine and Odontalgia

ArticleYear
Toothache and hearing loss: early symptoms of granulomatosis with polyangiitis (GPA).
    BMJ case reports, 2016, Jul-19, Volume: 2016

    Topics: Adult; Azathioprine; Cyclophosphamide; Diagnosis, Differential; Diphosphonates; Female; Granulomatos

2016